Innovation Pharmaceuticals Inc (IPIX)

[GreenBioAnalyst]

Nothing has changed. As predicted before, they are starting the Phase II trial. Maybe phase 2b. I was hoping it would be both PII and Phase III. But it's a great thing!

EC50, potential combo, frequency dosing, determining efficacy concentration without cytotoxicity, and post-entry inhibitory effects are the last readout. The narrative hasn't changed with Bril looking to be a direct antiviral (and indirect INFb pathway), an anti-inflammatory, and antimicrobial. Simply put, any drug out there to have a therapeutic benefit, it has to have immunomodulatory properties to be even beneficial to addressing anti-inflammatory portion associated with cytokine storm (via downregulation). How do you like them peaches?


Now grant funding, and/or pharma partnership is very likely to happen. IND announcement is due after the results come out! Science with Bril is real and TIH (the invisible hand) is printing money to fund this trial.

AGB